Clinical Trial

Observational Cross-reactivity Study for Colorectal Cancer Diagnosis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 1, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this observational study is to evaluate the false positive rate of the blood test based on molecular biomarkers and risk factors. A total of 250 patients diagnosed with various cancers and gastrointestinal diseases will be enrolled. The main question to be answered is Does the blood test have a low false positive rate in the main study population? Participants will donate a blood sample as part of their regular medical care for cancer diagnosis and give the consent to know their clinical risk factors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-20.
Trial Details
NCT Number NCT06889844
Lead Sponsor ADVANCED MARKER DISCOVERY S.L.
Conditions Colorectal Cancer
Enrollment 250 participants
Start Date 2023-04-17
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-01